Acta Scientific Dental Sciences (ASDS)(ISSN: 2581-4893)

Case Report Volume 7 Issue 5

UNICYSTIC Ameloblastoma of the Mandible About a Case and Review of the Literature

Hafida Mahchouche1, Fadila Saoudi2, Fatma Alloun3 and Rachid Lattafi4

1Department of Pathology and Oral Surgery, University Hospital of Beni-Messous, Algeria
2Professor, Department of Periodontology, CHU of Béni-Messous, Algeria
3Professor, Department of Epidemiology, CHU of Béni-Messous, Algeria
4Professor, Head of Department of Pathology and Oral Surgery, University Hospital of Beni-Messous, Algeria

*Corresponding Author: Hafida Mahchouche, Department of Pathology and Oral Surgery, University Hospital of Beni-Messous, Algeria.

Received: March 27, 2023; Published: April 25, 2023


Unicystic ameloblastoma is a rare benign entity which represents 5-15% of all intraosseous ameloblastomas, less aggressive and less invasive, which is observed mainly in younger patients. We report a case of unicystic ameloblastoma in a 25-year-old woman with a rapid evolution in a few months in the symphyseal and parasymphyseal region and illustrate the complexity of the differential diagnosis and the means of management with a brief review of recent literature.

Keywords:Ameloblastoma; Unicystic Ameloblastoma; Genetic Mutation


  1. Robinson L and Martinez MG. “Unicystic ameloblastoma. A prognostically distinct entity”. Cancer5 (1977): 2278-2285.
  2. Gardner DG and Corio RL “Plexiform unicysticameloblastoma: A variant of ameloblastoma with a low-recurrence rate after enucleation”. Cancer 53 (1984): 1730-1735.
  3. Kim SW., et al. “Conservative surgical treatment for ameloblastoma: a report of three cases”. Journal of the Korean Association of Oral and Maxillofacial Surgeons5 (2018): 242-247.
  4. Haq J., et al . “Argument for the conservative management of mandibular ameloblastomas”. British Journal of Oral and Maxillofacial Surgery9 (2016): 1001-1005.
  5. Hollows P., et al. “Ameloblastoma - a diagnostic problem”. British Dental Journal5 (2000): 243-244.
  6. Mohammed Asif S., et al. “Negligence or tumor aggressiveness: A case report of recurrent ameloblastoma”. SAGE Open Medical Case Reports 7 (2019): 2050313X19834416.
  7. Mendenhall WM., et al. “Ameloblastoma”. American Journal of Clinical Oncology6 (2007): 645-648.
  8. Regezi J., et al. “Oral pathology. Clinical pathological correlations”. Louis: Elsevier-Saunders 6 (2012): 270-277.
  9. Gardner DG., et al. “ In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathologies and genetics. Head and neck tumours. Lyon: IARC Press; 2005. p. 296-300.
  10. Soluk-tekkesin M and Wright JM. “The world health organization classification of odontogenic lesions: a summary of the changes of the 2017 (4th) edition”. Turkish Journal of Pathology
  11. Nadendla L. “Unusual imaging appearance of unicystic ameloblastoma”. Contemporary Clinical Dentistry4 (2012): 475-477.
  12. Meshram M., et al “Conservative Management of Unicystic Ameloblastoma in Young Patients: A Prospective Single-Center Trial and Review of Literature”. Journal of Maxillofacial and Oral Surgery3 (2017;): 333-341.
  13. Ahossi V., et al. “Mandibular plexiform unicystic ameloblastoma - about a case”. Odonto-Stomatological Review 38 (2009): 53-63.
  14. Bhutia O., et al. “Management of unicystic ameloblastoma of the mandible in a 5-year old child”. National Journal of Maxillofacial Surgery2 (2013): 232-234.
  15. Kalaskar R., et al. “Conservative management of unicystic ameloblastoma in a young child: Report of two cases”. Contemporary Clinical Dentistry4 (2011): 359-363.
  16. Manas Bajpai., et al. “Multilocular Unicystic Ameloblastoma of Mandible”. Hindawi Publishing Corporation, Case Reports in Dentistry (2013).
  17. Rosenstein T., et al. “Cystic ameloblastoma-behavior and treatment of 21 cases”. Journal of Oral and Maxillofacial Surgery11 (2001): 1311-1316.
  18. Neagu D., “Surgical management of ameloblastoma: Review of literature”. Journal of Clinical and Experimental Dentistry1 (2019): 70-75.
  19. Pogrel MA and Montes DM. “Is there a role for enucleation in the management of ameloblastoma?”. International Journal of Oral and Maxillofacial Surgery 38 (2009): 807-812.
  20. Hammarfjord O., et al. “Surgical treatment of recurring ameloblastoma, are there options?”. British Journal of Oral and Maxillofacial Surgery 51 (2013): 762-766.
  21. Gültekin SE., et al. “The landscape of genetic alterations in ameloblastomas relates to clinical features”. Virchows Archiv 472 (2018): 807-814.
  22. Gupta N., et al. “Unicystic ameloblastoma of the mandible”. Journal of Oral and Maxillofacial Pathology2 (2011): 228-231.
  23. Heikinheimo K., et al. “Novel Targets for the Treatment of Ameloblastoma”. Journal of Dental Research2 (2015): 237-240.
  24. Kurppa KJ., et al. “High frequency of BRAFV600E mutations in ameloblastoma: Recurrent oncogenic mutation in ameloblastoma”. The Journal of Pathology5 (2014): 492-498.
  25. Sweeney RT., et al. “Identification of recurrent SMO and BRAF mutations in ameloblastomas”. Nature Genetics7 (2014): 722-725.
  26. Brown NA., et al. “Activating FGFR2-RAS-BRAF Mutations in Ameloblastoma”. Clinical Cancer Research21 (2014): 5517-5526.
  27. Sithanandam G., et al. “Complete coding sequence of a human B-RAF cDNA and detection of B-RAF protein kinase with isozyme specific antibodies”. Oncogene12 (1990): 1775-1780.
  28. Sithanandam G., et al. “B-RAF and a B-RAF pseudogene are located on 7q in man”. Oncogene4 (1992): 795-799.
  29. Davies H., et al. “Mutations of the BRAF gene in human cancer”. Nature 417 (2002): 949-954.
  30. Bollag G., et al. “Vemurafenib: the first drug approved for BRAF-mutant cancer”. Nature Reviews Drug Discovery11 (2012): 873-886.
  31. Fernandes GS., et al “Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation”. BMC Cancer1 (2018).
  32. Tan S., et al. “BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response”. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology1 (2016): e5-e7.
  33. Faden DL and Algazi A. “Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma”. Journal of the National Cancer Institute (2017): djw109.


Citation: Hafida Mahchouche., et al. “UNICYSTIC Ameloblastoma of the Mandible About a Case and Review of the Literature".Acta Scientific Dental Sciences 7.5 (2023): 39-43.


Copyright: © 2023 Hafida Mahchouche., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.278

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US